Renewed interest in cellular and gene therapies has resulted in an increased demand to prepare products for Phase 1 and 2 clinical studies. The Food and Drug Administration has ruled that these materials must be manufactured under current Good Tissue Practice [GTP] or Good Manufacturing Practice [GMP] regulations In addition, these products are subject to rigorous quality control testing prior to release for use. The development and maintenance of such a manufacturing and testing infrastructure is both expensive and labor intensive. These services are provided at Baylor through the Cell Processing and Vector Production shared resource. This facility currently supports more than 20 IND cell and gene therapy studies, and is the only facility in the country to be designated as both a National Gene Vector Laboratory and a National Somatic Cell Therapy Laboratory. It produces nearly 1000 cellular therapy products and intermediates, and approximately 20 clinical grade vectors and cell banks annually. The associated Quality Control Laboratory tests and processes more than 12,000 samples annually. The Shared Resource has developed systems to ensure GMP/GTP compliance on an ongoing basis and has been successfully audited on multiple occasions by the FDA and accrediting organizations. It is estimated that this facility can offer both manufacturing and testing services at one quarter to one tenth the cost of using commercial contract organizations. In 2009 the shared resource will move to a new state of the art facility comprising 23 clean room suites with all of the associated quality control, quality assurance, flow cytometry and materials management infrastructure. This will provide investigators with unparalleled resources. We believe that a shared resource of this type is an essential component of a modern Cancer Center.

Public Health Relevance

The goal of this Shared Resource is to establish and follow uncompromising, scientifically sound standard conditions for production of cellular therapy products and vectors used in Phase I/II clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-05
Application #
8296120
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
5
Fiscal Year
2011
Total Cost
$70,069
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Yin, Jiani; Chen, Wu; Chao, Eugene S et al. (2018) Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome. Am J Hum Genet 102:296-308
Jones, Kathryn; Versteeg, Leroy; Damania, Ashish et al. (2018) Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease. Infect Immun 86:
Madan, Simran; Kron, Bettina; Jin, Zixue et al. (2018) Arginase overexpression in neurons and its effect on traumatic brain injury. Mol Genet Metab 125:112-117
Kornberg, Michael D; Bhargava, Pavan; Kim, Paul M et al. (2018) Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360:449-453
Koo, Sue-Jie; Szczesny, Bartosz; Wan, Xianxiu et al. (2018) Pentose Phosphate Shunt Modulates Reactive Oxygen Species and Nitric Oxide Production Controlling Trypanosoma cruzi in Macrophages. Front Immunol 9:202
Hsu, Joanne I; Dayaram, Tajhal; Tovy, Ayala et al. (2018) PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. Cell Stem Cell 23:700-713.e6
Singh, Sunita; Jangid, Rahul K; Crowder, Alyssa et al. (2018) Foxi3 transcription factor activity is mediated by a C-terminal transactivation domain and regulated by the Protein Phosphatase 2A (PP2A) complex. Sci Rep 8:17249
Lulla, Premal D; Hill, LaQuisa C; Ramos, Carlos A et al. (2018) The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma. Clin Adv Hematol Oncol 16:375-386
De Maio, Antonia; Yalamanchili, Hari Krishna; Adamski, Carolyn J et al. (2018) RBM17 Interacts with U2SURP and CHERP to Regulate Expression and Splicing of RNA-Processing Proteins. Cell Rep 25:726-736.e7
Bayrer, James R; Wang, Hongtao; Nattiv, Roy et al. (2018) LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun 9:4055

Showing the most recent 10 out of 991 publications